Fig. 4: Average sensitivity stratified by tumor size.

With Paige Prostate Alpha, pathologists were more likely to correctly identify smaller cancers, with greatest gains in sensitivity seen in the smallest tumors. Average sensitivity in detection of tumors under 0.6 mm increased from 46% without Paige Prostate Alpha to 83% with Paige Prostate Alpha.